Thyroid arterial embolization in a patient with congenital heart disease and refractory amiodarone-induced thyrotoxicosis

被引:1
作者
Bouca, Bruno [1 ]
Martins, Ana Claudia [1 ]
Bogalho, Paula [1 ]
Sousa, Lidia [2 ]
Bilhim, Tiago [3 ]
Gomes, Filipe Veloso [3 ]
Coimbra, Elia [3 ]
Agapito, Ana [1 ]
Silva-Nunes, Jose [1 ]
机构
[1] Ctr Hosp Univ Lisboa Cent, Endocrinol Diabet & Metab Dept, Lisbon, Portugal
[2] Ctr Hosp Univ Lisboa Cent, Cardiol Dept, Lisbon, Portugal
[3] Ctr Hosp Univ Lisboa Cent, Intervent Radiol Dept, Lisbon, Portugal
关键词
amiodarone; thyrotoxicosis; embolization; congenital heart disease; GRAVES-DISEASE; THERAPY; GUIDELINES;
D O I
10.1530/ETJ-21-0007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Amiodarone-induced thyrotoxicosis (AIT) can sometimes lead to life-threatening complications, especially in patients with congenital heart disease (CHD). We report the case of a patient with refractory AIT that was successfully treated with thyroid arterial embolization (TAE). Case report A 34-year-old man with complex cyanotic CHD complicated with heart failure (HF), pulmonary hypertension, and supraventricular tachyarrhythmias, was treated with amiodarone since 2013. In March 2019, he presented worsening of his cardiac condition and symptoms of thyrotoxicosis that were confirmed by laboratory assessment. Thiamazole 30 mg/day and prednisolone 40 mg/day were prescribed, but the patient experienced worsening of his cardiac condition with several hospital admissions in the next 5 months, albeit increasing dosages of thionamide and glucocorticoid and introduction of cholestyramine and lithium. Thyroidectomy was excluded due to the severity of thyrotoxicosis, and plasmapheresis was contraindicated due to the cardiac condition. TAE of the four thyroid arteries was then performed with no immediate complications. Progressive clinical and analytical improvement ensued with gradual reduction and suspension of medication with the patient returning to euthyroid state and his usual cardiac condition previous to the AIT. Conclusion For patients with medication refractoriness and whose condition precludes thyroidectomy, embolization of thyroid arteries may be an effective and safe option. Established facts Amiodarone-induced thyrotoxicosis (AIT) can be refractory to a combination therapy of thionamides and glucocorticoids. Restoration of euthyroidism is of paramount importance in heart failure (HF) patients. Emergency thyroidectomy for AIT unresponsive to medical therapy is recommended in patients with severe underlying cardiac disease or deteriorating cardiac function. Novel insights Thyroid arterial embolization (TAE) appeared as a salvage therapy in this patient. To the best of our knowledge, few case reports in the literature have described the embolization of the four thyroid arteries in AIT context. Endovascular embolization techniques are a valuable therapeutic option and can be considered in cases where standard forms of treatment are ineffective or involve unacceptable risks.
引用
收藏
页数:8
相关论文
共 22 条
  • [1] 2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction
    Bartalena, Luigi
    Bogazzi, Fausto
    Chiovato, Luca
    Hubalewska-Dydejczyk, Alicja
    Links, Thera P.
    Vanderpump, Mark
    [J]. EUROPEAN THYROID JOURNAL, 2018, 7 (02) : 55 - 66
  • [2] The various effects of amiodarone on thyroid function
    Bogazzi, F
    Bartalena, L
    Gasperi, M
    Braverman, LE
    Martino, E
    [J]. THYROID, 2001, 11 (05) : 511 - 519
  • [3] Impact of Lithium on Efficacy of Radioactive Iodine Therapy for Graves' Disease: A Cohort Study on Cure Rate, Time to Cure, and Frequency of Increased Serum Thyroxine After Antithyroid Drug Withdrawal
    Bogazzi, Fausto
    Giovannetti, Clara
    Fessehatsion, Rezene
    Tanda, Maria Laura
    Campomori, Alberto
    Compri, Emanuele
    Rossi, Giuseppe
    Ceccarelli, Claudia
    Vitti, Paolo
    Pinchera, Aldo
    Bartalena, Luigi
    Martino, Enio
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (01) : 201 - 208
  • [4] Partial thyroid arterial embolization for the treatment of hyperthyroidism
    Brzozowski, Krzysztof
    Piasecki, Piotr
    Ziecina, Piotr
    Frankowska, Emilia
    Jaroszuk, Andrzej
    Kaminski, Grzegorz
    Boguslawska-Walecka, Romana
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2012, 81 (06) : 1192 - 1196
  • [5] Comparison Between Total Thyroidectomy and Medical Therapy for Amiodarone-Induced Thyrotoxicosis
    Cappellani, Daniele
    Papini, Piermarco
    Pingitore, Alessandro
    Tomisti, Luca
    Mantuano, Michele
    Di Certo, Agostino M.
    Manetti, Luca
    Marconcini, Giulia
    Scattina, Ilaria
    Urbani, Claudio
    Morganti, Riccardo
    Marcocci, Claudio
    Materazzi, Gabriele
    Iervasi, Giorgio
    Martino, Enio
    Bartalena, Luigi
    Bogazzi, Fausto
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (01) : 242 - 251
  • [6] Effects of amiodarone therapy on thyroid function
    Cohen-Lehman, Janna
    Dahl, Peter
    Danzi, Sara
    Klein, Irwin
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2010, 6 (01) : 34 - 41
  • [7] Dedecjus M, 2009, THYROID RES, V2, DOI 10.1186/1756-6614-2-7
  • [8] Surgical Treatment of Amiodarone-Induced Thyrotoxicosis in an Adult with Congenital Heart Disease: An Anesthetists Perspective
    El-Asmar, Jose M.
    Naja, Ahmad Salaheddine
    Al-Halabi, Eliane
    [J]. AMERICAN JOURNAL OF CASE REPORTS, 2020, 21
  • [9] Galkin E V, 1994, Vestn Rentgenol Radiol, P29
  • [10] Management of Amiodarone-Induced Thyrotoxicosis at a Cardiac Transplantation Centre
    Isaacs, Michelle
    Costin, Monique
    Bova, Ron
    Barrett, Helen L.
    Heffernan, Drew
    Samaras, Katherine
    Greenfield, Jerry R.
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2018, 9